Literature DB >> 26041535

B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice.

Michael M Opata1, Melissa L Hollifield1, Frances E Lund2, Troy D Randall3, Robert Dunn4, Beth A Garvy5, David J Feola6.   

Abstract

B cells play a critical role in the clearance of Pneumocystis. In addition to production of Pneumocystis-specific Abs, B cells are required during the priming phase for CD4(+) T cells to expand normally and generate memory. Clearance of Pneumocystis was found to be dependent on Ag specific B cells and on the ability of B cells to secrete Pneumocystis-specific Ab, as mice with B cells defective in these functions or with a restricted BCR were unable to control Pneumocystis infection. Because Pneumocystis-specific antiserum was only able to partially protect B cell-deficient mice from infection, we hypothesized that optimal T cell priming requires fully functional B cells. Using adoptive transfer and B cell depletion strategies, we determined that optimal priming of CD4(+) T cells requires B cells during the first 2-3 d of infection and that this was independent of the production of Ab. T cells that were removed from Pneumocystis-infected mice during the priming phase were fully functional and able to clear Pneumocystis infection upon adoptive transfer into Rag1(-/-) hosts, but this effect was ablated in mice that lacked fully functional B cells. Our results indicate that T cell priming requires a complete environment of Ag presentation and activation signals to become fully functional in this model of Pneumocystis infection.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26041535      PMCID: PMC4491042          DOI: 10.4049/jimmunol.1500112

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.

Authors:  C C Goodnow; J Crosbie; S Adelstein; T B Lavoie; S J Smith-Gill; R A Brink; H Pritchard-Briscoe; J S Wotherspoon; R H Loblay; K Raphael
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

2.  Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia.

Authors:  Waleed Elsegeiny; Taylor Eddens; Kong Chen; Jay K Kolls
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

3.  Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.

Authors:  Kerry M Empey; Melissa Hollifield; Kevin Schuer; Francis Gigliotti; Beth A Garvy
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

5.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.

Authors:  J B Roths; C L Sidman
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.

Authors:  H Masur; M A Michelis; J B Greene; I Onorato; R A Stouwe; R S Holzman; G Wormser; L Brettman; M Lange; H W Murray; S Cunningham-Rundles
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

7.  Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice.

Authors:  J B Roths; C L Sidman
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Pneumocystis carinii infection in transgenic B cell-deficient mice.

Authors:  H Marcotte; D Levesque; K Delanay; A Bourgeault; R de la Durantaye; S Brochu; M C Lavoie
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

9.  CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.

Authors:  J A Wiley; A G Harmsen
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

10.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.

Authors:  A G Harmsen; M Stankiewicz
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  19 in total

1.  Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.

Authors:  Derrick R Samuelson; Nicholas M de la Rua; Tysheena P Charles; Sanbao Ruan; Christopher M Taylor; Eugene E Blanchard; Meng Luo; Alistair J Ramsay; Judd E Shellito; David A Welsh
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

2.  An Emerging Role of B Cell Immunity in Susceptibility to Pneumocystis Pneumonia.

Authors:  Jay K Kolls
Journal:  Am J Respir Cell Mol Biol       Date:  2017-03       Impact factor: 6.914

3.  The Major Surface Glycoprotein of Pneumocystis murina Does Not Activate Dendritic Cells.

Authors:  Monica Sassi; Geetha Kutty; Gabriela A Ferreyra; Lisa R Bishop; Yueqin Liu; Ju Qiu; Da Wei Huang; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

Review 4.  New advances in understanding the host immune response to Pneumocystis.

Authors:  J Claire Hoving; Jay K Kolls
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

5.  The trophic life cycle stage of Pneumocystis species induces protective adaptive responses without inflammation-mediated progression to pneumonia.

Authors:  Heather M Evans; Beth A Garvy
Journal:  Med Mycol       Date:  2018-11-01       Impact factor: 4.076

6.  A Novel CD4+ T Cell-Dependent Murine Model of Pneumocystis-driven Asthma-like Pathology.

Authors:  Taylor Eddens; Brian T Campfield; Katelin Serody; Michelle L Manni; William Horne; Waleed Elsegeiny; Kevin J McHugh; Derek Pociask; Kong Chen; Mingquan Zheng; John F Alcorn; Sally Wenzel; Jay K Kolls
Journal:  Am J Respir Crit Care Med       Date:  2016-10-01       Impact factor: 21.405

7.  Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice.

Authors:  Guixiang Dai; Kristin Noell; Gisbert Weckbecker; Jay K Kolls
Journal:  mSphere       Date:  2021-05-05       Impact factor: 4.389

Review 8.  Immune reconstitution inflammatory syndrome associated with pulmonary pathogens.

Authors:  Radha Gopal; Rekha R Rapaka; Jay K Kolls
Journal:  Eur Respir Rev       Date:  2017-01-03

9.  CD4(+) T-Cell-Independent Secondary Immune Responses to Pneumocystis Pneumonia.

Authors:  Nicholas M de la Rua; Derrick R Samuelson; Tysheena P Charles; David A Welsh; Judd E Shellito
Journal:  Front Immunol       Date:  2016-05-11       Impact factor: 7.561

10.  Fungal Infections Associated With the Use of Novel Immunotherapeutic Agents.

Authors:  Marilia Bernardes; Tobias M Hohl
Journal:  Curr Clin Microbiol Rep       Date:  2020-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.